We found that LPS accelerated the development of tongue SCC from tongue leukoplakia in vivo, elevated IFITM4P expression, induced a tumor-immunosuppressive effect through PD-L1 upregulation, and increased the therapeutic sensitivity of PD-1 mAb therapy. Here, IFITM4P is linked to leukoplakia of tongue.